Prabhudas Lilladhar
BYRCS reported disappointing 4Q results with high costs and decline in Change in Estimates | Target | Reco revenue of ~57% YoY (due high sales return) leading to EBITDA and PAT loss. Subdued market conditions led to sales return of placed stocks (even though...
Number of FII/FPI investors decreased from 214 to 203 in Dec 2025 qtr
More from Bayer Cropscience Ltd.
Recommended